Gregory Murphy (R-NC)

No Handouts for Drug Advertisements Act

H.R. 3010 · House bill Taxation

A Republican bill with 3 Democratic cosponsors · See all 4 cosponsors

Last activity — Referred to the House Committee on Ways and Means.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill, called the "No Handouts for Drug Advertisements Act," aims to amend the Internal Revenue Code of 1986 to disallow tax deductions for advertising and promotional expenses related to direct-to-consumer advertising of certain prescription drugs. This would affect sponsors of prescription drugs and owners of outsourcing facilities. The changes would apply to expenses paid after the bill's enactment.

Yes· 3 of 7

  • Scored +2

    Does this raise the taxes companies pay?

    By disallowing tax deductions for drug advertising, it effectively increases the tax burden on pharmaceutical companies.

  • Scored +2

    Does this lower the price of prescription medicines?

    By disallowing advertising deductions, the bill might encourage drug companies to reduce prices.

  • Scored +1

    Does this reduce what the federal government owes?

    The bill could lead to a slight reduction in the national debt by increasing government revenue through reduced tax deductions.

The opposite

  • Scored -1

    Would business owners be better off under this?

    Pharmaceutical company owners may see a negative impact due to reduced tax deductions.